Moderna takes off after a positive test on a coronavirus vaccine

0
29


Moderna Inc. (MRNA) – Get a report Stocks jumped in trade before market release on Wednesday after the drug maker reported uniformly positive data from an early trial of its experimental coronavirus vaccine.Moderna said the phase 1 trial of MRNA-1273, its proposed coronavirus vaccine candidate, induced antibody reactions in the 45 participating patients, with no serious side effects, after two injections spanning a period four weeks. The results open the door to a larger study of some 30,000 patients, scheduled for July 27, and follow on from the positive results of vaccine studies reported earlier this week by drug maker Pfizer Inc. (PFE) – Get a report.



LEAVE A REPLY

Please enter your comment!
Please enter your name here